Literature DB >> 31048939

Drug-induced movement disorders.

Stephen R Duma1,2, Victor Sc Fung1,2.   

Abstract

Entities:  

Keywords:  dystonia; neuroleptic malignant syndrome; parkinsonism; serotonin syndrome; tardive dyskinesia

Year:  2019        PMID： 31048939      PMCID： PMC6478951          DOI： 10.18773/austprescr.2019.014

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  22 in total

Review 1.  Evidence-based guideline: treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Authors:  Roongroj Bhidayasiri; Stanley Fahn; William J Weiner; Gary S Gronseth; Kelly L Sullivan; Theresa A Zesiewicz
Journal:  Neurology       Date:  2013-07-30       Impact factor: 9.910

2.  An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method.

Authors:  Ronald J Gurrera; Stanley N Caroff; Abigail Cohen; Brendan T Carroll; Francis DeRoos; Andrew Francis; Steven Frucht; Sanjay Gupta; James L Levenson; Ahsan Mahmood; Stephan C Mann; Michael A Policastro; Patricia I Rosebush; Henry Rosenberg; Perminder S Sachdev; Julian N Trollor; Varadaraj R Velamoor; Charles B Watson; Jayne R Wilkinson
Journal:  J Clin Psychiatry       Date:  2011-06-28       Impact factor: 4.384

Review 3.  Movement disorder emergencies.

Authors:  Christopher M Kipps; Victor S C Fung; Padraic Grattan-Smith; Gregory M de Moore; John G L Morris
Journal:  Mov Disord       Date:  2005-03       Impact factor: 10.338

4.  A Validation Study of the International Consensus Diagnostic Criteria for Neuroleptic Malignant Syndrome.

Authors:  Ronald J Gurrera; Gino Mortillaro; Varadaraj Velamoor; Stanley N Caroff
Journal:  J Clin Psychopharmacol       Date:  2017-02       Impact factor: 3.153

Review 5.  Acute and subacute drug-induced movement disorders.

Authors:  Pierre R Burkhard
Journal:  Parkinsonism Relat Disord       Date:  2014-01       Impact factor: 4.891

Review 6.  Tardive dyskinesia syndromes: current concepts.

Authors:  Camila Catherine H Aquino; Anthony E Lang
Journal:  Parkinsonism Relat Disord       Date:  2014-01       Impact factor: 4.891

Review 7.  The parkinsonism-hyperpyrexia syndrome.

Authors:  Edward J Newman; Donald G Grosset; Peter G E Kennedy
Journal:  Neurocrit Care       Date:  2008-08-20       Impact factor: 3.210

8.  Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.

Authors:  C Warren Olanow; Karl Kieburtz; Olivier Rascol; Werner Poewe; Anthony H Schapira; Murat Emre; Helena Nissinen; Mika Leinonen; Fabrizio Stocchi
Journal:  Mov Disord       Date:  2013-04-29       Impact factor: 10.338

Review 9.  Drug-Induced Extrapyramidal Syndromes: Implications for Contemporary Practice.

Authors:  Stanley N Caroff; E Cabrina Campbell
Journal:  Psychiatr Clin North Am       Date:  2016-06-23

Review 10.  Psychostimulants and movement disorders.

Authors:  Andres Asser; Pille Taba
Journal:  Front Neurol       Date:  2015-04-20       Impact factor: 4.003
View more
  9 in total

1.  Involvement of adenosine A1 and A2A receptors on guanosine-mediated anti-tremor effects in reserpinized mice.

Authors:  C M Massari; L C Constantino; N F Marques; L B Binder; M Valle-León; M López-Cano; V Fernández-Dueñas; F Ciruela; C I Tasca
Journal:  Purinergic Signal       Date:  2020-07-28       Impact factor: 3.765

2.  A Case Report of Baclofen- and Clozapine-Induced Dyskinesia: A Movement Disorder.

Authors:  Maisha Maliha; Zinath Roksana; Priyata Dutta; Md Y Mamoon; Mohammed Q Islam
Journal:  Cureus       Date:  2022-05-17

3.  Psychotropic medications induced parkinsonism and akathisia in people attending follow-up treatment at Jimma Medical Center, Psychiatry Clinic.

Authors:  Assefa Kumsa; Liyew Agenagnew; Beza Alemu; Shimelis Girma
Journal:  PLoS One       Date:  2020-07-02       Impact factor: 3.240

4.  Neuroleptic Malignant Syndrome: Early Diagnosis Saves Lives in Low-Resource Settings.

Authors:  Micheal Kiyingi; Felix Bongomin; Mark Kizito; Mark Kaddumukasa
Journal:  Int Med Case Rep J       Date:  2020-08-24

5.  Drug-induced bruxism.

Authors:  Leanne Teoh; Geraldine Moses
Journal:  Aust Prescr       Date:  2019-08-01

Review 6.  The Use of Risperidone in Behavioral and Psychological Symptoms of Dementia: A Review of Pharmacology, Clinical Evidence, Regulatory Approvals, and Off-Label Use.

Authors:  Ismaeel Yunusa; Marie Line El Helou
Journal:  Front Pharmacol       Date:  2020-05-20       Impact factor: 5.810

Review 7.  Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies.

Authors:  Thomas Opladen; Eduardo López-Laso; Elisenda Cortès-Saladelafont; Toni S Pearson; H Serap Sivri; Yilmaz Yildiz; Birgit Assmann; Manju A Kurian; Vincenzo Leuzzi; Simon Heales; Simon Pope; Francesco Porta; Angeles García-Cazorla; Tomáš Honzík; Roser Pons; Luc Regal; Helly Goez; Rafael Artuch; Georg F Hoffmann; Gabriella Horvath; Beat Thöny; Sabine Scholl-Bürgi; Alberto Burlina; Marcel M Verbeek; Mario Mastrangelo; Jennifer Friedman; Tessa Wassenberg; Kathrin Jeltsch; Jan Kulhánek; Oya Kuseyri Hübschmann
Journal:  Orphanet J Rare Dis       Date:  2020-05-26       Impact factor: 4.123

8.  Serotonin Syndrome in the Emergency Department.

Authors:  Michelle Hernandez; Michael Walsh; Trilok Stead; Anines Quinones; Latha Ganti
Journal:  Cureus       Date:  2019-12-06

Review 9.  Drug-Induced Hyperthermia Review.

Authors:  Michael Horseman; Ladan Panahi; George Udeani; Andrew S Tenpas; Rene Verduzco; Pooja H Patel; Daniela Z Bazan; Andrea Mora; Nephy Samuel; Anne-Cecile Mingle; Lisa R Leon; Joseph Varon; Salim Surani
Journal:  Cureus       Date:  2022-07-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.